MONKEYPOX MEDIA ADVISORY: Infectious Disease Specialists From Regional Special Pathogen Treatment Center Available to Discuss Monkeypox Causes and Treatments

Multiple cases of monkeypox have surfaced in Europe and the U.S. that do not appear to be linked to travel, causing concern among the medical community that this infectious disease is spreading through sexual contact or other close interactions.

TGen, ASU, NAU, UArizona, ADHS compile 100,000 sequenced genomes of COVID

The Arizona COVID-19 Genomics Union, led by Paul Keim and others throughout the state, is positioning Arizona to play a role in the planned U.S. Pathogen Genomics Centers of Excellence, a national network funded by the U.S. Centers for Disease Control and Prevention that would expand and deepen infectious disease collaborations between U.S. public health agencies and universities.

ACI, CDC Launch Redesigned “Healthy Schools, Healthy People” Website

The American Cleaning Institute (ACI) launched a new website for the Healthy Schools, Healthy People initiative, a joint effort of ACI and the Centers for Disease Control and Prevention (CDC) to promote hand hygiene and cleaning practices as a means to prevent the spread of infectious disease in schools and reduce illness-related absenteeism.

UCLA seeks volunteers for study of COVID-19’s impact on health to support “longhaul” survivors

UCLA researchers are seeking participants for an innovative study examining the impact of COVID-19 on survivors who continue battling health issues long after they were infected and thought to have recovered, known informally as “long COVID” and “longhaulers.”

AACI Applauds Approval of COVID-19 Vaccine, Supports Widespread Vaccination Efforts

The Association of American Cancer Institutes (AACI) commends the U.S. Food and Drug Administration (FDA) for its swift action to grant Emergency Use Authorization (EUA) to Pfizer’s COVID-19 vaccine.

American College of Rheumatology Secures $7M Grant to Address Gaps in Lupus Care and Treatment

The American College of Rheumatology (ACR) was recently awarded a $7M grant to reduce inequities in symptom recognition, care and disease management of systemic lupus erythematosus (lupus). The grant, which will be led by the ACR’s Collaborative Initiatives (COIN) department, begins on Sept. 30.

U.S. Workers Need Paid Sick Leave to Help Stop the Spread of Coronavirus

One-third of Americans do not have access to paid sick leave. Only the U.S. and Japan do not mandate a national sick leave benefit. Currently, seven states in the U.S. mandate that employers provide paid sick leave benefits. Given the latest information from the U.S. CDC regarding the potential impact that the coronavirus could have on the nation, researchers urge that it is critical to consider the role paid sick leave has in stopping the spread of a contagious virus.

UCLA Fielding School of Public Health faculty experts available for media covering novel coronavirus (COVID-19)

UCLA Fielding School of Public Health experts available for media covering novel coronavirus (COVID-19) include: Dr. Robert J. Kim-Farley serves as professor-in-residence of epidemiology and community health sciences at the Fielding School. His previous roles include director of the Division of…

Recognize an overdose, save a life

Every day nearly 200 people die from an overdose of drugs or from alcohol poisoning, with opioids responsible for the majority. Recognizing the signs and knowing how to respond to medical emergencies, including carrying and administering naloxone in cases of opioid overdose, can save lives says the ASA.

UCLA Public Health Experts on Coronavirus and related issues

Faculty experts at UCLA’s Fielding School of Public Health with significant scientific and public health expertise with regards to infectious diseases, including coronavirus, include: Anne Rimoin, Phd, MPH, an epidemiologist with more than 18 years of experience working internationally and…

FY 2020 Spending Bill Funds Critical Initiatives While Neglecting Urgent Priorities

The spending bill passed today is a welcome step forward. Allocations in the bill will strengthen public health and research efforts during the year ahead and will provide critical support for important goals. At the same time, the legislation in its final form also brings inadequate responses to current and urgent challenges with the potential for long-term and costly consequences.

House Drug Pricing Bill Serves Patients, Public Health

H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act passed by the House of Representatives today introduces critically needed and significant steps to reduce costs and improve access to life-saving therapies for conditions including HIV and hepatitis C. Importantly, the legislation also brings essential resources to combat antibiotic resistance, find and develop new infection fighting drugs and bring them to market. The balanced approach of this legislation will serve patients and public health.